The following adverse reactions have been reported following administration of Artelac 0.32% w/v Eye Drops Single Dose Unit.
Eye disorder:
Very rare (<1/10,000):
Cases of corneal calcification have been reported very rarely in association with the use of phosphate containing eye drops in some patients with significantly damaged corneas.
Not known:
Brief blurred vision or a slight stinging sensation on instilling Artelac 0.32% w/v Eye Drops Single Dose Unit.
Reporting of suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via Yellow Card Scheme Website:
www.mhra.gov.uk/yellowcard